Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Johnson, Derek C ^a   Chasela, Charles ^a   Maliwichi, Madalitso ^a   Mwafongo, Albert ^a   Akinkuotu, Adesola ^a   Moses, Agness ^a   Jamieson, Denise J ^b   Kourtis, Athena P ^b   King, Caroline C ^b   van der Horst, Charlie ^a   Hosseinipour, Mina C ^a  

^a UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN; TENOFOVIR DISOPROXIL;

ADULT; AGE; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; DRUG RESPONSE; DRUG USE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALAWI; MALE; PREDICTION; PREGNANCY; PREGNANT WOMAN; SEX DIFFERENCE;

ADENINE; ADOLESCENT; ADULT; ANTI-HIV AGENTS; BENZOXAZINES; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; CREATININE; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; MALAWI; MALE; ORGANOPHOSPHONATES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RENAL INSUFFICIENCY;

EID: 84864413236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041011     Document Type: Article

References (34)

1. USAID HIV/AIDS Health Profile. In: USAID/Malawi, editor (2010) Lilongwe. pp. 4.
2. Malawi Go (2009) Malawi HIV and AIDS Monitoring and Evaluation Report 2009: Follow Up to the United Nations Declaration of Commitment on HIV and AIDS". In: Office of the President and Cabinet DoN, HIV and AIDS, editor (2009) Lilongwe.
3. UNAIDS Malawi HIV and AIDS Monitoring and Evaluation Report: 2008-2009. In: UNAIDS, editor (2010) Lilongwe.
4. Woodward CL, Hall AM, Williams IG, Madge S, Copas A, et al.((2009)) Tenofovir-associated renal and bone toxicity. HIV Med 10:: 482--487.
5. Organization WH,((2010)) Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. WHO Press.
6. Labarga P, Medrano J, Seclen E, Poveda E, Rodriguez-Novoa S, et al.((2010)) Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients. AIDS 24:: 777--779.
7. Wever K, van Agtmael MA, Carr,((2010)) A Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. J Acquir Immune Defic Syndr 55:: 78--81.
8. Chi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, et al.((2010)) Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia. J Acquir Immune Defic Syndr 54:: 63--70.
9. Landman R, Poupard M, Diallo M, Ngom Gueye NF, Diakhate N, et al.((2009)) Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patients. J Int Assoc Physicians AIDS Care (Chic) 8:: 379--384.
10. Young B, Buchacz K, Moorman A, Wood KC, Brooks JT,((2009)) Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study. AIDS Patient Care STDS 23:: 589--592.
11. Struik GM, den Exter RA, Munthali C, Chipeta D, van Oosterhout JJ, et al.((2011)) The prevalence of renal impairment among adults with early HIV disease in Blantyre, Malawi. Int J STD AIDS 22:: 457--462.
12. Altripla [package insert]. Wallingford Center CB-MSaGS, LLC; 2011 Sept.
13. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, et al.((2010)) Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 362:: 2271--2281.
14. Robert C, Bollinger SB, Celentano David, Chariyalertsak Suwat, Grinstzejn Beatriz,et al. (2003) A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 In Serodiscordant Couples. In: Division of AIDS USNIoAaID, editor(2003).
15. Cockcroft DW, Gault MH,((1976)) Prediction of creatinine clearance from serum creatinine. Nephron 16:: 31--41.
16. Davison JM, Dunlop W,((1980)) Renal hemodynamics and tubular function normal human pregnancy. Kidney Int 18:: 152--161.
17. Alper AB, Yi Y, Webber LS, Pridjian G, Mumuney AA, et al.((2007)) Estimation of glomerular filtration rate in preeclamptic patients. Am J Perinatol 24:: 569--574.
18. Tweya H, Gareta D, Chagwera F, Ben-Smith A, Mwenyemasi J, et al.((2010)) Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi. Trop Med Int Health 15 Suppl 1:: 82--89.
19. Jones R, Stebbing J, Nelson M, Moyle G, Bower M, et al.((2004)) Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. J Acquir Immune Defic Syndr 37:: 1489--1495.
20. Manzi M, Zachariah R, Teck R, Buhendwa L, Kazima J, et al.((2005)) High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health 10:: 1242--1250.
21. Goicoechea M, Liu S, Best B, Sun S, Jain S, et al.((2008)) Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. J Infect Dis 197:: 102--108.
22. Wools-Kaloustian K, Gupta SK, Muloma E, Owino-Ong'or W, Sidle J, et al.((2007)) Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant 22:: 2208--2212.
23. Horwood C, Haskins L, Vermaak K, Phakathi S, Subbaye R, et al.((2010)) Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women's health services. Trop Med Int Health.
24. Deti EK, Thiebaut R, Bonnet F, Lawson-Ayayi S, Dupon M, et al.((2010)) Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. HIV Med 11:: 308--317.
25. Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, et al.((2008)) Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant 23:: 741--746.
26. Nowicki M, Kokot F, Kokot M, Bar A, Dulawa J,((1994)) Renal clearance of endogenous erythropoietin in patients with proteinuria. Int Urol Nephrol 26:: 691--699.
27. Laradi A, Mallet A, Beaufils H, Allouache M, Martinez F,((1998)) HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol 9:: 2327--2335.
28. Abbott KC, Hypolite I, Welch PG, Agodoa LY,((2001)) Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 14:: 377--383.
29. Pilsczek FH, Renn W, Hardin H, Schmulling RM,((2008)) Clinical laboratory values during diabetic pregnancies. J Ayub Med Coll Abbottabad 20:: 3--6.
30. Veille JC, McNeil S, Hanson R, Smith N,((1998)) Renal Hemodynamics: Longitudinal Study from the Late Fetal Life to One Year of Age. J Matern Fetal Investig 8:: 6--10.
31. Burden RP, Boyd WN, Aber GM,((1979)) Structural and functional changes in the renal circulation after complicated pregnancy. Nephron 24:: 183--192.
32. Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N,((2007)) Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 86:: 648--651.
33. Abeysena C, Jayawardana P, de ASR,((2010)) Maternal haemoglobin level at booking visit and its effect on adverse pregnancy outcome. Aust N Z J Obstet Gynaecol 50:: 423--427.
34. Organization WH (2005) Summary Country Profile for HIV/AIDS Treatment Scale-up. In: Malawi WCOf, editor(2005).